CBT vs NGVT
CBT: Cabot is a leader in specialty chemicals, providing critical carbon-based materials that enhance the performance of tires, energy storage, and industrial applications globally. NGVT: Ingevity is a specialty chemicals and materials company providing high-performance carbon and polymer technologies used in automotive, pavement, and industrial applications.
Side-by-side fundamentals
| Metric | CBT | NGVT | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $75.61 | $71.41 | |
| Market cap | $3.9B | $2.5B | |
| P/E as of 2026-10-08 | 21.00 | 48.56 | CBT lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | 1.14 | n/a | |
| Net margin FY2025, SEC XBRL | +8.9% | -14.3% | CBT higher |
| Gross margin FY2025, SEC XBRL | +25.3% | +39.5% | NGVT higher |
| Operating margin FY2025, SEC XBRL | +16.7% | +35.9% | NGVT higher |
| ROE FY2025, SEC XBRL | +19.4% | -562.6% | CBT higher |
| ROA FY2025, SEC XBRL | +8.7% | -10.1% | CBT higher |
| Debt / equity as of 2026-09-03 | 0.79 | 25.59 | CBT lower |
| Revenue growth (YoY) as of 2026-09-03 | -4.7% | -12.4% | CBT higher |
| Revenue CAGR (3y) SEC XBRL | -4.9% | -11.2% | CBT higher |
| Dividend yield as of 2026-09-03 | +2.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 9 | 0 | CBT higher |
| Beta as of 2026-09-03 | 0.74 | 1.33 | |
| 1-year return as of 2026-10-08 close | +3.5% | +31.3% | NGVT higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.